AltaThera Pharmaceuticals, LLC — Form D/A
AltaThera Pharmaceuticals, LLC of CHICAGO, IL, a company, filed a Form D amendment with the SEC on 2019-08-22. The offering totals $4.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-08-22
- Form: D/A
- Accession: 0001604121-19-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.5M
- Remaining: $2.5M
- Investors: 2
- Date of first sale: 2019-04-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-338880
Issuer
- Name: AltaThera Pharmaceuticals, LLC
- CIK: 0001604121
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 200 SOUTH WACKER DRIVE - SUITE 3100, CHICAGO, IL, 60606
- Phone: (312)445-8900
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Jodi Devlin | Executive Officer | Chicago, IL |
| Brandon Kashfian | Executive Officer | Chicago, IL |
| Stephen Osullivan | Executive Officer | Chicago, IL |
| John Flavin | Director | Chicago, IL |
| Brandon Kashfian | Director | Chicago, IL |
| Stephen O?Sullivan | Director | Chicago, IL |
| Stephen O?Sullivan | Executive Officer | Chicago, IL |
| James Wittenberg | Executive Officer | Chicago, IL |
| Merrill Barden | Executive Officer | Chicago, IL |
| John Somberg | Executive Officer | Chicago, IL |
| Rick White | Executive Officer | Bainbridge Island, WA |
| Jay Welsh | Executive Officer | Chicago, IL |
| Stephen O'Sullivan | Director | Chicago, IL |
| Stephen O'Sullivan | Executive Officer | Chicago, IL |
| Mahlaqa Patel | Executive Officer | Chicago, IL |
| Merrill Bardin | Executive Officer | Chicago, IL |
Other filings by this issuer (6)
More